Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Comments on Draft Guidance, “Expedited Program for Serious Condions-Accelerated Approval of Drugs and Biologics”
HOME
/
Policy Interactions
/
Comments on Draft Guidance, “Expedited Program for Serious Condions-Accelerated Approval of Drugs and Biologics”